Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChina Pacific Regulatory News (CPIC)

Share Price Information for China Pacific (CPIC)

Share Price is delayed by 15 minutes
Get Live Data
26.60    0.00 (0.00%)
Bid:
20.40
Ask:
21.20
Spread: 0.80 (3.922%)
Market Cap: $51.18b
CPIC Live PriceLast checked at - London Stock Exchange

Intraday China Pacific Share Chart

  • This share is an international stock.

Poll results for the 2025 AGM

10 Jun 2026 13:34

RNS Number : 8041H
China Pacific Insurance Grp Co. Ltd
10 June 2026
 

10 June 2026

CHINA PACIFIC INSURANCE (GROUP) CO., LTD.

(A joint stock company incorporated in the People's Republic of China with limited liability)

Announcement on Poll Results for the 2025 Annual General Meeting and Distribution of Final Dividends and Adjustment to the Conversion Price of Convertible Bonds

The 2025 annual general meeting (the "AGM") of China Pacific Insurance (Group) Co., Ltd. (the "Company" or "CPIC") was held on Wednesday, 10 June 2026 at 1:00 p.m. (Beijing time).

I. AGM ATTENDANCE AND VOTING ARRANGEMENTS

As at the date of the AGM, the Company has issued 6,845,041,455 A shares and 2,775,300,000 H shares. The shareholders are entitled to attend the AGM and vote for or against all resolutions proposed at the AGM.

The details for the attendance of the shareholders and the authorised proxies at the AGM were as follows:

Number of shareholders and proxies attending the meeting

1,143

Of which: Number of holders of A shares

1,142

Number of holders of H shares

1

Total number of the voting shares held by attendees

5,712,046,986

Of which: Total number of shares held by holders of A shares

4,460,773,821

Total number of shares held by holders of H shares

1,251,273,165

Percentage of total number of voting shares of the Company (%)

59.374680

Of which: Shares held by holders of A shares

46.368144

Shares held by holders of H shares

13.006536

 

The AGM was convened in accordance with the requirements of the Company Law of the People's Republic of China and the articles of association of the Company (the "Articles of Association"), and was chaired by Mr. FU Fan, Chairman of the board of directors of the Company.

The executive directors of the Company being Mr. FU Fan and Mr. ZHAO Yonggang, non-executive directors Mr. HUANG Dinan, Ms. LU Qiaoling, Mr. WANG Tayu, Ms. WANG Yuhua, Mr. CHEN Ran, Mr. ZHOU Donghui and Mr. John Robert DACEY, independent non-executive directors Ms. CHEN Xin, Ms. LAM Tyng Yih, Elizabeth, Ms. LO Yuen Man, Elaine, Mr. CHIN Hung I David and Mr. WONG Hin Wing, and employee director Ms. ZHOU Liyun attended the AGM.

Computershare Hong Kong Investor Services Limited, the Company's H share registrar, was appointed as the scrutineer for the vote-taking at the AGM. King & Wood Shanghai Office was appointed as the witnessing lawyer at the AGM.

II. POLL RESULTS

All resolutions as set out in the notice of the AGM dated 20 May 2026 were voted by poll. The poll results in respect of the resolutions proposed at the AGM were as follows:

Ordinary Resolutions

Number of Votes

(%)

Total Number of Votes

For

Against

Abstain

1.

To consider and approve the report of the Board of Directors of the Company for the year 2025

5,700,797,995

99.803066

8,415,625

0.147331

2,833,366

0.049603

5,712,046,986

As more than half of the votes were cast in favour of this resolution, the resolution was duly passed as an ordinary resolution.

2.

To consider and approve the proposed profit distribution plan of the Company for the year 2025

5,711,689,510

99.993742

298,050

0.005218

59,426

0.001040

5,712,046,986

As more than half of the votes were cast in favour of this resolution, the resolution was duly passed as an ordinary resolution.

3.

To consider and approve the appointment of auditors of the Company for the year 2026

5,710,694,960

99.976330

945,750

0.016557

406,276

0.007113

5,712,046,986

As more than half of the votes were cast in favour of this resolution, the resolution was duly passed as an ordinary resolution.

4.

To consider and approve the budget for external donation projects of the Company for 2026

5,699,530,723

99.780880

9,806,247

0.171676

2,710,016

0.047444

5,712,046,986

As more than half of the votes were cast in favour of this resolution, the resolution was duly passed as an ordinary resolution.

5.

To consider and approve the high-quality development plan of the Company for 2026-2028

4,956,813,280

(86.778230

754,210,830

13.203863

1,022,876

0.017907

5,712,046,986

As more than half of the votes were cast in favour of this resolution, the resolution was duly passed as an ordinary resolution.

6.

To consider and approve the proposed election of Mr. GE Ming as an Independent Director of the tenth session of the Board of Directors of the Company

5,631,622,085

98.592013

79,989,425

1.400363

435,476

0.007624

5,712,046,986

As more than half of the votes were cast in favour of this resolution, the resolution was duly passed as an ordinary resolution.

7.

To consider and approve the revision of the directors' remuneration management system of the Company

5,704,524,482

99.868305

7,088,928

0.124104

433,576

0.007591

5,712,046,986

As more than half of the votes were cast in favour of this resolution, the resolution was duly passed as an ordinary resolution.

8.

To consider and approve the measures for the remuneration management of senior management personnel of the Company

5,704,485,423

99.867621

7,097,087

0.124247

464,476

0.008132

5,712,046,986

As more than half of the votes were cast in favour of this resolution, the resolution was duly passed as an ordinary resolution.

9.

To consider and approve the Directors' remuneration plan of the Company for the year 2026

5,711,170,001

99.984647

411,109

0.007197

465,876

0.008156

5,712,046,986

As more than half of the votes were cast in favour of this resolution, the resolution was duly passed as an ordinary resolution.

10.

To consider and approve the formulation of the measures for the wage determination mechanism of the Company

5,705,335,301

99.882499

6,254,809

0.109503

456,876

0.007998

5,712,046,986

As more than half of the votes were cast in favour of this resolution, the resolution was duly passed as an ordinary resolution.

11.

To consider and approve the authorisation by the shareholders' meeting to the Board of Directors to determine the interim profit distribution plan for 2026

5,711,704,310

99.994001

299,050

0.005235

43,626

0.000764

5,712,046,986

As more than half of the votes were cast in favour of this resolution, the resolution was duly passed as an ordinary resolution.

Special Resolution

Number of Votes

(%)

For

Against

Abstain

Total Number of Votes

12.

As a special matter, to consider and approve the grant of a general mandate by the shareholders' meeting of the Company to the Board of Directors to issue new Shares (details of the resolution are set out in the circular)

4,897,231,307

85.735137

814,204,626

14.254165

611,053

0.010698

5,712,046,986

As more than two thirds of the votes were cast in favour of this resolution, the resolution was duly passed as a special resolution.

Note: The appraisal report on performance of Directors of the Company for the year 2025, the report on performance of independent Directors of the Company for the year 2025 and the special report on the status of related party transactions of the Company for the year 2025 are not listed here as they are submitted at the AGM for shareholders' review only and no resolution is required for them. For details, please refer to the Company's notice of the AGM dated 20 May 2026.

In accordance with relevant laws and regulations, the appointment of Mr. GE Ming acting as an independent non-executive director of the Company shall be subject to the approval of the regulatory authorities.

The full text of each resolution was set out in the Company's notice of the AGM dated 20 May 2026.

III. PAYMENT OF FINAL DIVIDENDS

The Company will distribute an annual dividend of RMB1.15 (tax inclusive) per share (the "Final Dividends") for the year ended 31 December 2025 in cash. Holders of GDRs whose names appear on the register of GDR holders of the Company will be entitled to receive the Final Dividends, which will be paid via Citibank, N.A, the Company's depositary, in accordance with the terms of the deposit agreement.

IV. ADJUSTMENT TO THE CONVERSION PRICE OF HK$15,556,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2030

References are made to the announcements of the Company dated 10 September 2025, 11 September 2025 and 18 September 2025 in relation to the issue of zero coupon convertible bonds due 2030 in an aggregate principal amount of HK$15,556,000,000 (the "Convertible Bonds").

The terms and conditions of the Convertible Bonds as set out in the offering circular of the Company dated 10 September 2025 (the "CB Terms and Conditions") provided, among other things, that if the Company pays or makes any Capital Distribution (as defined in the CB Terms and Conditions), the Conversion Price (as defined in the CB Terms and Conditions) shall be adjusted by multiplying the Conversion Price in force immediately before such Capital Distribution by the following fraction:

A-B

B

Where:

A. is the Current Market Price (as defined in the CB Terms and Conditions) per H Share on the date on which the Capital Distribution is first publicly announced; and

B. is the Fair Market Value (as defined in the CB Terms and Conditions) of the portion of Capital Distribution attributable to one H Share.

Such adjustment shall become effective on the date that such Capital Distribution is actually made or, if a record date is fixed therefor, immediately after such record date.

The final dividend has been approved by the AGM on 10 June 2026. With effect from 22 June 2026, being the day immediately after the record date of H Shares, the Conversion Price of the Convertible Bonds will be adjusted from the initial Conversion Price of HK$39.04 per H Share (the "Initial Conversion Price") to the adjusted Conversion Price of HK$37.51 per H Share (the "Adjustment"), in accordance with the CB Terms and Conditions. Save for the abovementioned Adjustment to the Conversion Price, the other terms of the Convertible Bonds remain unchanged.

As at the date of this announcement, the aggregate principal amount under the Convertible Bonds that remains outstanding is HK$15,556,000,000. Immediately following the Adjustment, the maximum number of H Shares issuable by the Company upon full conversion of the Convertible Bonds at the adjusted Conversion Price of HK$37.51 per H Share will be 414,716,075 H Shares, representing an increase of 16,252,961 H Shares (the "Additional Conversion Shares") from 398,463,114 H Shares based on the Initial Conversion Price.

The Additional Conversion Shares will be issued and allotted pursuant to the general mandate approved by the Shareholders at 2024 annual general meeting of the Company held on 11 June 2025 (the "General Mandate"). The Company is entitled to issue and allot a maximum of 555,060,000 H Shares pursuant to the General Mandate, which is sufficient to cover the maximum number of Conversion Shares to be issued after the Adjustment of the Conversion Price pursuant to the CB Terms and Conditions (currently 414,716,075 H Shares).

Application will be made to The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange") for the listing of, and permission to deal in, the Additional Conversion Shares on the Hong Kong Stock Exchange.

 

By Order of the Board of Directors

China Pacific Insurance (Group) Co., Ltd.

FU Fan

Chairman

 

About CPIC

CPIC is a joint stock company established under the laws of the People's Republic of China with limited liability.

CPIC's registered office is located at 1 South Zhongshan Road, Huangpu District, Shanghai, the People's Republic of China.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEAAKEFDAKEFA
Date   Source Headline
22nd Jun 20269:48 amRNSDirector/PDMR Shareholding
10th Jun 20261:34 pmRNSPoll results for the 2025 AGM
8th Jun 202612:30 pmRNSApproval of Director's Appointment Qualification
26th May 202611:05 amRNSAppointment of Vice President
20th May 202610:26 amRNSNotice of the 2025 Annual General Meeting
30th Apr 20269:50 amRNSDirector/PDMR Shareholding
28th Apr 202610:48 amRNSPublication of Summaries of Solvency Reports
28th Apr 202610:36 amRNS2026 First Quarter Report
22nd Apr 202610:35 amRNS2025 Sustainability Report
21st Apr 202611:10 amRNS2026 Q1 Results Presentation
14th Apr 202610:07 amRNSPDMR Shareholding
26th Mar 202612:32 pmRNSPublication of Annual Results Presentation
26th Mar 202612:22 pmRNSPublication of Summaries of Solvency Reports
26th Mar 202612:16 pmRNSCPIC 2025 Annual Report
18th Mar 20269:40 amRNSConvening of 2025 Annual Results Presentation
26th Jan 202611:16 amRNSApproval of Director's Appointment Qualification
19th Jan 20269:35 amRNSAnnouncement relating to Premium Income
23rd Dec 202512:55 pmRNSApproval of AoA and Dissolution of the BOS
23rd Dec 202512:55 pmRNSApproval of AoA and Dissolution of the BOS
16th Dec 20259:17 amRNSAnnouncement relating to Premium Income
9th Dec 202510:10 amRNSRelevant presentations on 2025 investor day
4th Dec 20259:58 amRNSApproval of Director's Appointment Qualification
27th Nov 20259:06 amRNSDirector Shareholding
21st Nov 20259:10 amRNSElection of Employee Director
13th Nov 20259:11 amRNSAnnouncement relating to Premium Income
30th Oct 202511:02 amRNSSummaries of the Quarterly Solvency Reports
30th Oct 20259:54 amRNS2025 Third Quarter Report
21st Oct 202510:41 amRNS2025 Q3 Results Presentation
16th Oct 202511:36 amRNSAnnouncement relating to Premium Income
19th Sep 20257:00 amRNSPublication of Offering Circular of Bonds
18th Sep 202510:51 amRNSAnnouncement relating to Premium Income
18th Sep 202510:43 amRNSCompletion of the Issue of Convertible Bonds
18th Sep 202510:40 amRNSNotice of Listing of Convertible Bonds
11th Sep 20257:00 amRNSProposed issue of Bonds under General Mandate
10th Sep 202512:24 pmRNSProposed issue of Convertible Bonds
29th Aug 202512:35 pmRNSAnnouncement on Poll Results for the EGM
28th Aug 20252:24 pmRNSResignation of Supervisor
28th Aug 20251:25 pmRNSPublication of Summaries of Solvency Reports
28th Aug 20251:24 pmRNSPublication of 2025 Interim Results Presentation
28th Aug 20251:17 pmRNS2025 Interim Report
21st Aug 202511:47 amRNSConvening of 2025 Interim Results Presentation
13th Aug 202510:50 amRNSAnnouncement relating to Premium Income
11th Aug 202511:21 amRNSNotice of EGM
30th Jul 20254:01 pmRNSAmendments to the AoA and dissolution of the BOS
15th Jul 202511:23 amRNSAnnouncement relating to Premium Income
24th Jun 202510:23 amRNSResignation of Director of the Board
13th Jun 202510:15 amRNSAnnouncement relating to Premium Income
11th Jun 202512:58 pmRNSPoll Results for the 2024 AGM
6th Jun 202510:48 amRNSApproval of Appointment Qualification
21st May 202511:19 amRNSNotice of the 2024 Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.